The piece recaps Phase 3 weight loss of up to 28.3% and notes TRIUMPH-3 didn't show fewer major heart events. Lilly aims to file in early 2027.
Recap by typeshit. Full story at The Motley Fool.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
Philstar Life looks at famous names linked to Ozempic for weight loss. Only a search title came through, so details are thin until you open the source.
An international food and agribusiness expert links growing interest in fibre to the spread of GLP-1 drugs. Details are thin beyond the claim itself.
Early trial results suggest the shot could one day help people hold onto weight loss after they come off GLP-1 drugs.
Piotr Alvarez says HILIC flips elution order for semaglutide and tirzepatide, helping catch impurities, while TFA faces likely PFAS limits.
A shared link to stories about how the spread of Ozempic and similar drugs is adding new body image strain inside families.
Loading…